Skip to main content
logo
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.400
+0.180 (14.75%)
At close: Nov 21, 2025, 4:00 PM EST
1.445
+0.045 (3.19%)
After-hours: Nov 21, 2025, 7:59 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Novel Therapeutics
391.70K
Log In
Log In
Log In
Novel Therapeutics Growth
-73.93%
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
391.70K
Log In
Log In
Log In
United States Growth
-73.93%
Log In
Log In
Log In